CoChat

EULAR points to consider for the use of big data in rheumatic and musculoskeletal diseases

Open access
Gossec, Laure, Kedra, Joanna, Servy, Hervé, Pandit, Aridaman, Stones, Simon, Berenbaum, Francis, Finckh, Axel, Baraliakos, Xenofon, Stamm, Tanja A, Gomez-Cabrero, David, Pristipino, Christian, Choquet, Remy, Burmester, Gerd R, Radstake, Timothy R D J · 2020 · Annals of the Rheumatic Diseases
Cited by 90

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Tremendous opportunities for health research have been unlocked by the recent expansion of big data and artificial intelligence. However, this is an emergent area where recommendations for optimal use and implementation are needed. The objective of these European League Against Rheumatism (EULAR) points to consider is to guide the collection, analysis and use of big data in rheumatic and musculoskeletal disorders (RMDs). METHODS: A multidisciplinary task force of 14 international experts was assembled with expertise from a range of disciplines including computer science and artificial intelligence. Based on a literature review of the current status of big data in RMDs and in other fields of medicine, points to consider were formulated. Levels of evidence and strengths of recommendations were allocated and mean levels of agreement of the task force members were calculated. RESULTS: Three overarching principles and 10 points to consider were formulated. The overarching principles address ethical and general principles for dealing with big data in RMDs. The points to consider cover aspects of data sources and data collection, privacy by design, data platforms, data sharing and data analyses, in particular through artificial intelligence and machine learning. Furthermore, the points to consider state that big data is a moving field in need of adequate reporting of methods and benchmarking, careful data interpretation and implementation in clinical practice. CONCLUSION: These EULAR points to consider discuss essential issues and provide a framework for the use of big data in RMDs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/annrheumdis-2019-215694

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 90

Metadata

Authors
Gossec, L., Kedra, J., Servy, H., Pandit, A., Stones, S., Berenbaum, F., Finckh, A., Baraliakos, X., Stamm, T. A., Gomez-Cabrero, D., Pristipino, C., Choquet, R., Burmester, G. R., & Radstake, T. R. D. J.
Venue
Annals of the Rheumatic Diseases
Publisher
Elsevier BV
Published
2020-01
Volume
79
Issue
1
Pages
69-76
ISSN
0003-4967 (ISSN-L)
OpenAlex
W2949769604
Cited by
90
References
13
FWCI
3.17
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: EULAR points to consider for the use of big data in rheumatic and musculoskeletal diseases. https://app.cochat.ai/papers/10.1136/annrheumdis-2019-215694
The paper
Gossec, L., Kedra, J., Servy, H., Pandit, A., Stones, S., Berenbaum, F., Finckh, A., Baraliakos, X., Stamm, T. A., Gomez-Cabrero, D., Pristipino, C., Choquet, R., Burmester, G. R., & Radstake, T. R. D. J. (2020). EULAR points to consider for the use of big data in rheumatic and musculoskeletal diseases. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2019-215694

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.